Neurent Medical announced today that Cigna Healthcare intends to provide coverage for its Neuromark system for chronic ...

Neurent Medical, a leader in non-surgical treatments for chronic rhinitis, today announced that Cigna Healthcare will provide coverage for NEUROMARK treatment of the posterior nasal nerve by removing ...

CI to cover RhinAer for chronic rhinitis starting Sept. 15, expanding access to a minimally invasive, office-based treatment.

RhinAer provides ENT physicians with a comprehensive solution for the treatment of chronic rhinitis, addressing sources of rhinorrhea and congestion.

Aerin Medical Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced that Cigna Healthcare will provide coverage for RhinAer® treatment of the posterior nasal ...

Cigna Enables Coverage for RhinAer® Policy Update Validates Clinical Value and Expands Patient Access to Innovative Chronic Rhinitis Treatment Aerin Medical Inc., a leader in minimally invasive ...

This administration seems to relish the cruelty of these actions. “Alligator Alcatraz” is an example of this. It’s in the ...

Allergic rhinitis, often called hay fever, mimics cold symptoms but isn’t caused by a virus or bacteria. Non-allergic rhinitis, triggered by irritants like smoke, strong odours, or weather changes, ...

Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.

The US Food and Drug Administration (FDA) has granted 510 (k) clearance to Neurent Medical's NEUROMARK system for the treatment of individuals with chronic rhinitis.